{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:41:11Z","timestamp":1790970071267,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2023YFC3304200"],"award-info":[{"award-number":["2023YFC3304200"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.pbb.2025.174015","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T02:12:07Z","timestamp":1746065527000},"page":"174015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Crisugabalin, a ligand for the \u03b1\u03b4 subunit of voltage-gated calcium channels, exhibits no obvious abuse potential in rodents"],"prefix":"10.1016","volume":"252","author":[{"given":"Xiaoli","family":"Gou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qidi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansheng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyuan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongjun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linggao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2025.174015_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2397","article-title":"Melatonin attenuates morphine-induced conditioned place preference in Wistar rats","volume":"11","author":"Alshehri","year":"2021","journal-title":"Brain and Behavior"},{"key":"10.1016\/j.pbb.2025.174015_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2975","article-title":"Effect of risperidone on morphine-induced conditioned place preference and dopamine receptor D2 gene expression in male rat hippocampus","volume":"13","author":"Arani","year":"2023","journal-title":"Brain and Behavior"},{"key":"10.1016\/j.pbb.2025.174015_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173485","article-title":"Rapastinel accelerates loss of withdrawal signs after repeated morphine and blunts relapse to conditioned place preference","volume":"221","author":"Armstrong","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2025.174015_bb0020","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/ene.13950","article-title":"European academy of neurology guideline on trigeminal neuralgia","volume":"26","author":"Bendtsen","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.pbb.2025.174015_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107850","article-title":"In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: drug discrimination and thermoregulation","volume":"208","author":"Berquist","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2025.174015_bb0030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/14728222.2017.1328057","article-title":"Targeting dorsal root ganglia and primary sensory neurons for the treatment of chronic pain","volume":"21","author":"Berta","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.pbb.2025.174015_bb0035","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.euroneuro.2017.08.430","article-title":"How addictive are gabapentin and pregabalin? A systematic review","volume":"27","author":"Bonnet","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2025.174015_bb0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.31647","article-title":"Association of Gabapentinoids with the risk of opioid-related adverse events in surgical patients in the United States","volume":"3","author":"Bykov","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.pbb.2025.174015_bb0045","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1080\/14737175.2016.1202764","article-title":"Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use","volume":"16","author":"Calandre","year":"2016","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.pbb.2025.174015_bb0050","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1007\/s00213-016-4349-z","article-title":"Nucleus accumbens hyperpolarization-activated cyclic nucleotide-gated channels modulate methamphetamine self-administration in rats","volume":"233","author":"Cao","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2025.174015_bb0055","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.2174\/0929867329666220407093727","article-title":"Review of voltage-gated Calcium Channel \u03b12\u03b4 subunit ligands for the treatment of chronic neuropathic pain and insight into structure-activity relationship (SAR) by pharmacophore modeling","volume":"29","author":"Chen","year":"2022","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pbb.2025.174015_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00044011-200929030-00006","article-title":"Pregabalin in the treatment of chronic pain: an overview","volume":"29","author":"Chiechio","year":"2009","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.pbb.2025.174015_bb0065","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","article-title":"Chronic pain: an update on burden, best practices, and new advances","volume":"397","author":"Cohen","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2025.174015_bb0070","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1124\/jpet.117.247551","article-title":"Binding characteristics and analgesic effects of Mirogabalin, a novel ligand for the alpha2delta subunit of voltage-gated calcium channels","volume":"365","author":"Domon","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2025.174015_bb0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainresbull.2023.03.012","article-title":"VU0155041, a positive allosteric modulator of mGluR4, in the nucleus accumbens facilitates extinction and inhibits the reinstatement of morphine-induced conditioned place preference in male rats","volume":"197","author":"Ebrahimi","year":"2023","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pbb.2025.174015_bb0080","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40265-017-0700-x","article-title":"Abuse and misuse of Pregabalin and gabapentin","volume":"77","author":"Evoy","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.pbb.2025.174015_bb0085","first-page":"15","article-title":"Center for Drug Evaluation and Research. Approval package for application number 021724 (Pregabalin)","volume":"021724s000","author":"FDA","year":"2004","journal-title":"Pharmacology Review(s)"},{"key":"10.1016\/j.pbb.2025.174015_bb0090","author":"FDA"},{"key":"10.1016\/j.pbb.2025.174015_bb0095","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1021\/acsmedchemlett.1c00416","article-title":"Piperazinyl bicyclic derivatives as selective ligands of the \u03b12\u03b4-1 subunit of voltage-gated calcium channels","volume":"12","author":"Fern\u00e1ndez","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.pbb.2025.174015_bb0100","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1074\/jbc.271.10.5768","article-title":"The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel","volume":"271","author":"Gee","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbb.2025.174015_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107926","article-title":"The gabapentinoid drugs and their abuse potential","volume":"227","author":"Goins","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pbb.2025.174015_bb0110","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1124\/jpet.120.000315","article-title":"Pharmacology and mechanism of action of HSK16149, a selective ligand of alpha2delta subunit of voltage-gated Calcium Channel with analgesic activity in animal models of chronic pain","volume":"376","author":"Gou","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2025.174015_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2024.105731","article-title":"Preclinical evaluation of abuse potential of the peripherally-restricted kappa opioid receptor agonist HSK21542","author":"Gou","year":"2024","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.pbb.2025.174015_bb0120","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.25614","article-title":"GABA analogue HSK16149 in Chinese patients with diabetic peripheral neuropathic pain","volume":"7","author":"Guo","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.pbb.2025.174015_bb0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00296-016-3481-8","article-title":"An overview of treatment approaches for chronic pain management","volume":"37","author":"Hylands-White","year":"2016","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.pbb.2025.174015_bb0130","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1111\/bcp.15352","article-title":"Fatalities associated with gabapentinoids in England (2004\u20132020)","volume":"88","author":"Kalk","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pbb.2025.174015_bb0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/FBP.0000000000000187","article-title":"Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocannabinol in humans discriminating [INCREMENT]9-tetrahydrocannabinol","volume":"27","author":"Lile","year":"2016","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2025.174015_bb0140","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2147\/JPR.S442595","article-title":"Update on treating painful diabetic peripheral neuropathy: a review of current US guidelines with a focus on the Most recently approved management options","volume":"17","author":"Mallick-Searle","year":"2024","journal-title":"J. Pain Res."},{"key":"10.1016\/j.pbb.2025.174015_bb0145","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s40122-020-00189-x","article-title":"Gabapentinoid benefit and risk stratification: mechanisms over myth","volume":"9","author":"McAnally","year":"2020","journal-title":"Pain Ther."},{"key":"10.1016\/j.pbb.2025.174015_bb0150","doi-asserted-by":"crossref","DOI":"10.1177\/2042098619836032","article-title":"Abuse potential of mirogabalin in recreational polydrug users","volume":"10","author":"Mendell","year":"2019","journal-title":"Therapeutic Advances in Drug Safety"},{"key":"10.1016\/j.pbb.2025.174015_bb0155","author":"PMDA"},{"key":"10.1016\/j.pbb.2025.174015_bb0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0024-3205(91)90012-Z","article-title":"Comparison of the discriminative stimulus effects of midazolam after intracranial and peripheral administration in the rat","volume":"49","author":"Sannerud","year":"1991","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2025.174015_bb0165","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s40263-014-0164-4","article-title":"Misuse and abuse of Pregabalin and gabapentin: cause for concern?","volume":"28","author":"Schifano","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pbb.2025.174015_bb0170","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ddr.21437","article-title":"Evaluation of samidorphan, a \u03bc-opioid antagonist, in a drug discrimination assay in rats","volume":"79","author":"Sgro","year":"2018","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.pbb.2025.174015_bb0175","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.2147\/DDDT.S326583","article-title":"Oleanolic acid attenuates morphine withdrawal symptoms in rodents: association with regulation of dopamine function","volume":"15","author":"Shi","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.pbb.2025.174015_bb0180","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.coph.2005.11.003","article-title":"The mechanisms of action of gabapentin and pregabalin","volume":"6","author":"Sills","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.pbb.2025.174015_bb0185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pbb.2007.04.021","article-title":"The blockade of AMPA-kainate and NMDA receptors in the dorsal periaqueductal gray reduces the effects of diazepam withdrawal in rats","volume":"87","author":"Souza-Pinto","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2025.174015_bb0190","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1177\/02698811231215415","article-title":"Abuse potential assessment of the dual orexin receptor antagonist daridorexant in rats","volume":"37","author":"Steiner","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2025.174015_bb0195","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00213-010-2088-0","article-title":"Comparison of self-administration behavior and responsiveness to drug-paired cues in rats running an alley for intravenous heroin and cocaine","volume":"214","author":"Su","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2025.174015_bb0200","article-title":"Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: observational study based on the UK clinical practice research datalink and Office for National Statistics death records","volume":"16","author":"Tsai","year":"2019","journal-title":"PLoS Med."},{"key":"10.1016\/j.pbb.2025.174015_bb0205","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/s41596-020-0296-6","article-title":"An operant social self-administration and choice model in rats","volume":"15","author":"Venniro","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.pbb.2025.174015_bb0210","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/BF00439549","article-title":"Discriminative stimulus properties of midazolam: comparison with other benzodiazepines","volume":"97","author":"Woudenberg","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2025.174015_bb0215","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/00498254.2022.2049396","article-title":"Pharmacokinetics and metabolism of mirogabalin, a novel \u03b12\u03b4 ligand, in rats and monkeys","volume":"52","author":"Yamamura","year":"2022","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pbb.2025.174015_bb0220","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.pbb.2011.10.023","article-title":"Subjective, psychomotor, and physiological effects of pregabalin alone and in combination with oxycodone in healthy volunteers","volume":"100","author":"Zacny","year":"2012","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.pbb.2025.174015_bb0225","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2024.3410","article-title":"Efficacy and safety of Crisugabalin (HSK16149) in adults with Postherpetic neuralgia","author":"Zhang","year":"2024","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.pbb.2025.174015_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104599","article-title":"Chronic neuropathic pain is more than a perception: systems and methods for an integral characterization","volume":"136","author":"Zolezzi","year":"2022","journal-title":"Neurosci. Biobehav. Rev."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305725000620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305725000620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:45:00Z","timestamp":1762231500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305725000620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":46,"alternative-id":["S0091305725000620"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2025.174015","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crisugabalin, a ligand for the \u03b12\u03b4 subunit of voltage-gated calcium channels, exhibits no obvious abuse potential in rodents","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2025.174015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"174015"}}